Taiwan Biomaterial Balance Sheet Health
Financial Health criteria checks 4/6
Taiwan Biomaterial has a total shareholder equity of NT$624.5M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$697.7M and NT$73.2M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$299.77m |
| Equity | NT$624.45m |
| Total liabilities | NT$73.24m |
| Total assets | NT$697.69m |
Financial Position Analysis
Short Term Liabilities: 6649's short term assets (NT$360.6M) exceed its short term liabilities (NT$19.5M).
Long Term Liabilities: 6649's short term assets (NT$360.6M) exceed its long term liabilities (NT$53.7M).
Debt to Equity History and Analysis
Debt Level: 6649 is debt free.
Reducing Debt: 6649 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 6649 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 6649 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.